| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/12/2003 | US20030109514 Platinum derivative pharmaceutical formulations |
| 06/12/2003 | US20030109510 Pharmaceutical formulations comprising a combination of (R,R)-formoterol and budesonide and the use of such formulations in medicine, particularly in the prophylaxis and treatment of respiratory diseases |
| 06/12/2003 | US20030109506 Treating vitamin D responsive diseases |
| 06/12/2003 | US20030109496 Use of polysiloxanes containing at least one quaternary ammonium group as formulation auxiliary in formulations of larvicidal and/or ovicidal active compounds and to compositions containing active materials and carriers |
| 06/12/2003 | US20030109490 Composite stimulating iNOS enzyme which induce immuno-reactant nitric oxide synthesis and process for preparing the same |
| 06/12/2003 | US20030109475 Introducing a gene capable of modulating the genotype and phenotype into two or more tissues following systemic administration. The gene can be introduced into a mammalian host by way of an expression vector either as naked DNA or |
| 06/12/2003 | US20030109442 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally |
| 06/12/2003 | US20030109429 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 06/12/2003 | US20030109427 Highly concentrated, low salt-containing, biologically active syrup form of IGF-I or variant thereof and methods for its preparation are provided. This novel syrup form of IGF-I has an IGF-I concentration of at least about 250 mg/ml, a density |
| 06/12/2003 | US20030109424 Solutions have enhanced viscosities that reduce the risk of damage to intraocular tissues during intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. |
| 06/12/2003 | US20030109422 Process for the preparation of pharmaceutical formulations containing lactoferrin |
| 06/12/2003 | US20030109025 Particles containing coated living micro-organisms, and method for producing same |
| 06/12/2003 | US20030108743 Coated particles, methods of making and using |
| 06/12/2003 | US20030108705 Rigid polyvinyl alcohol encases fabric care, dishwashing, water- softening, laundry, rinse aid, antibacterial or refill compositions for a trigger type spray |
| 06/12/2003 | US20030108669 Methods for micronization of hydrophobic drugs |
| 06/12/2003 | US20030108626 Method and composition for dry eye treatment |
| 06/12/2003 | US20030108616 Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
| 06/12/2003 | US20030108615 Also comprising a binder, a taste masking layer, a lubricant, and a binder/dissolution enhancer; storage stability; discoloration inhibition; materials handling; easy dosage adjustment |
| 06/12/2003 | US20030108614 Drug delivery of biocompatible particles comprising a mixture of iron and carbon having improved adsorption of a biologically active material to be transported target tissue and maintaining it there; materials handling |
| 06/12/2003 | US20030108612 Metallic nanoparticles for inhibition of bacterium growth |
| 06/12/2003 | US20030108611 Bioactive particulates having a cationic surfactant adsorbed on their surfaces to provide superior adhesion to a biological substrate, e.g., an insect, teeth, bone, nails, chitin, feathers, plants, mucous, skin; drug delivery |
| 06/12/2003 | US20030108610 An aqueous sol for localized drug delivery including a modifier polymer which gels at body temperature; the release rate of the drug is altered and controlled by increasing or decreasing polymer concentration; surgical adhesions |
| 06/12/2003 | US20030108609 Capable of suspending beneficial agents and homogeneously dispensing them over an extended period of time at body temperature and at low flow rates; storage stability; injections; grafting; proteinaceous drugs; antiagglomerants |
| 06/12/2003 | US20030108607 Film forming compositions containing sucralose |
| 06/12/2003 | US20030108606 Pharmaceutical formulation |
| 06/12/2003 | US20030108605 Mineral supplement |
| 06/12/2003 | US20030108604 Coiled fibers; binders; granulation, kneading |
| 06/12/2003 | US20030108603 Mixture of protein, hydrophilic polymer, group 1a alkyl sulfate and sugar |
| 06/12/2003 | US20030108602 Controlling releasing |
| 06/12/2003 | US20030108601 Liquid pharmaceutical for oral delivery |
| 06/12/2003 | US20030108600 Ubidecarenone compositions and capsules containing the same |
| 06/12/2003 | US20030108599 Surface treating with nonionic surfactant coating |
| 06/12/2003 | US20030108598 Mixture of carotenoid in vegetable oil ; therapy for vision defects |
| 06/12/2003 | US20030108597 Application of lipid vehicles and use for drug delivery |
| 06/12/2003 | US20030108596 Lipophilic drug compositions |
| 06/12/2003 | US20030108592 Measurement, dilution, accuracy dosage |
| 06/12/2003 | US20030108590 Water swelling; releasing active material |
| 06/12/2003 | US20030108588 Reduce restenosis coating on medical device |
| 06/12/2003 | US20030108586 Using gonadotropin releasing hormone antagonist |
| 06/12/2003 | US20030108581 Mammary glands; reducing residues; multisheet pad |
| 06/12/2003 | US20030108575 Stabilized oral suspension formulation |
| 06/12/2003 | US20030108565 Sustained releas of protein using polymer and hydrophobic ion binding; inducing immunology response; autoimmune disease, anticancer agent |
| 06/12/2003 | US20030108541 Plant extract |
| 06/12/2003 | US20030108525 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 06/12/2003 | US20030108519 Genetic engineered interferons; mucous membrane administering; stimulation of immunology response |
| 06/12/2003 | US20030108511 Biocompatible, crosslinked polymer; surgical gel |
| 06/12/2003 | US20030108510 Synergistic mixture of rutin, escin and bufemin; branching of arteries, veins |
| 06/12/2003 | US20030107149 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 06/12/2003 | DE20305447U1 Pharmaceutical product comprises a carrier strip, which holds at least one active substance, held in a plastic foil bag provided with a break line running across its width |
| 06/12/2003 | CA2469134A1 Novel peptide and pharmaceutical use of the same |
| 06/12/2003 | CA2469119A1 Pharmaceutical compositions comprising active vitamin d compounds |
| 06/12/2003 | CA2468672A1 Antimicrobial composition comprising soy oil, rice bran oil and jojoba oil |
| 06/12/2003 | CA2468558A1 "compressed annular tablet with molded triturate tablet for oral and intraoral" |
| 06/12/2003 | CA2468539A1 Delivery of medicaments to the nail |
| 06/12/2003 | CA2468044A1 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 06/12/2003 | CA2466757A1 Method for treating ocular hypertension |
| 06/12/2003 | CA2466697A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/12/2003 | CA2465455A1 Compound |
| 06/12/2003 | CA2465395A1 Transdermal therapeutic systems containing steroid hormones and containing propylene glycol monocaprylate |
| 06/11/2003 | EP1317926A1 Xenon inhalant for pain treatment |
| 06/11/2003 | EP1317925A1 Microgranules of Ursodeoxycholic acid |
| 06/11/2003 | EP1317921A1 Gel or solution containing dihydrotestosterone, its manufacture and use |
| 06/11/2003 | EP1317916A2 Films containing modified starch |
| 06/11/2003 | EP1317479A2 Methods and compositions for diseases associated with amyloidosis |
| 06/11/2003 | EP1317439A1 Acid-sensitive compounds, preparation and uses thereof |
| 06/11/2003 | EP1317412A1 Compounds and compositions for delivering active agents |
| 06/11/2003 | EP1317309A2 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant |
| 06/11/2003 | EP1317306A2 Transdermal electrotransport device and method for manufacturing same |
| 06/11/2003 | EP1317304A1 Slow release pharmaceutical preparation and method of administering same |
| 06/11/2003 | EP1317288A2 Method and composition for treating tumors by selective induction of apoptosis |
| 06/11/2003 | EP1317286A2 Contraception process and administration form for the same |
| 06/11/2003 | EP1317272A2 Composition for improving the cell protection comprising a lipophilic antioxidant an a hydrophilic antioxidant |
| 06/11/2003 | EP1317257A2 Plaster cover for children |
| 06/11/2003 | EP1317256A2 Pharmaceutical composition having modified carrier |
| 06/11/2003 | EP1317255A1 Delivery capsules |
| 06/11/2003 | EP1317254A2 Sustained release particle dispersion |
| 06/11/2003 | EP1317253A2 Biological component comprising artificial membrane |
| 06/11/2003 | EP1317252A2 Pharmaceutical composition having specific water activity |
| 06/11/2003 | EP1267976A4 Microencapsulated fragrances and methods of coating microcapsules |
| 06/11/2003 | EP1228077B1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities |
| 06/11/2003 | EP1158966B1 Loaded bacterial ghosts as carrier and targeting vehicles |
| 06/11/2003 | EP1131065B1 Dialkylfumarates for the treatment of autoimmune diseases |
| 06/11/2003 | EP1121159B1 Vapour dispensing device |
| 06/11/2003 | EP0979070B1 Adherent microcapsules containing biologically active ingredients |
| 06/11/2003 | EP0938325B1 Methods for sterilizing male mammals |
| 06/11/2003 | EP0879051B1 Rate-controlled transdermal administration of risperidone |
| 06/11/2003 | EP0810855B1 Polyalkylene block copolymers as surface modifiers for nanoparticles |
| 06/11/2003 | EP0731690B1 Liposomes with enhanced entrapment capacity, production and use thereof |
| 06/11/2003 | CN2555022Y Antiphlogistic ointment for appendicitis |
| 06/11/2003 | CN1423659A Recombinant gelatins |
| 06/11/2003 | CN1423581A Article comprising a diffuser with flow control features |
| 06/11/2003 | CN1423564A APLIDINE treatment of cancers |
| 06/11/2003 | CN1423562A Perfusion liquid preparations for ophthalmic operations |
| 06/11/2003 | CN1423560A Male contraceptive formulation comprising norethisterone |
| 06/11/2003 | CN1423559A Controlled-release compositions containing opioid agonist and antagonist |
| 06/11/2003 | CN1423557A Intracorporeal medicaments for photodynamic treatment of disease |
| 06/11/2003 | CN1423556A Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 06/11/2003 | CN1423555A 掩蔽味道的涂料组合物 Taste-masking coating composition |
| 06/11/2003 | CN1423554A Method for producing a moulded body containing starch |
| 06/11/2003 | CN1423553A Particulate active agent for pulmonary application |